Prostate Cancer - Results from #20980

The economics of abiraterone acetate for castration-resistant prostate cancer - Abstract March 26, 2014

Sequencing of agents for castration-resistant prostate cancer - Abstract March 26, 2014

Efficacy of silodosin in patients undergoing brachytherapy: A randomized trial involving a pressure flow study - Abstract March 26, 2014

Usefulness of uretral endosprothesis in the management of urinary retention after brachytherapy for localized prostate cancer - Abstract March 25, 2014

Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: A population-based study - Abstract March 25, 2014

Current results on PSA-based prostate cancer detection - Abstract March 25, 2014

Melanoma of non-sun exposed skin in a man with previous prostate cancer: Recognition of a recently confirmed association - Abstract March 25, 2014

Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk - Abstract March 25, 2014

The use of androgen deprivation therapy (ADT) and chemotherapeutic agents in New Zealand men with prostate cancer - Abstract March 25, 2014

An update on occupation and prostate cancer - Abstract March 25, 2014

Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer - Abstract March 25, 2014

Radiation safety considerations for the use of (223)RaCl(2) DE in men with castration-resistant prostate cancer - Abstract March 25, 2014

Salvage therapy for castration-refractory prostate cancer resistant to docetaxel - Abstract March 25, 2014

Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer - Abstract March 24, 2014

The Postoperative Morbidity Index: A quantitative weighing of postoperative complications applied to urological procedures - Abstract March 24, 2014

NICE unable to give the go ahead to new prostate cancer drug in preliminary recommendations March 24, 2014

A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapy - Abstract March 24, 2014

A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer - Abstract March 24, 2014

A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: A step towards practical implementation - Abstract March 24, 2014

The Quadrella: A novel approach to analyzing optimal outcomes after permanent seed prostate brachytherapy - Abstract March 24, 2014

Page 1050 of 1438